Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerAimery de Gramont, Andrea Bonetti, Arié Figer et al.|Journal of Clinical Oncology|2000Cited by 3.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upArndt Vogel, Erika Martinelli, Andrés Cervantes et al.|Annals of Oncology|2018Cited by 1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal CancerMarc Peeters, Jennifer Gansert, Timothy Price et al.|Journal of Clinical Oncology|2010Cited by 1k
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upRadka Obermannová, Elizabeth Smyth, María Alsina et al.|Annals of Oncology|2022Cited by 646